What are the recommended starting and maximum doses for each calcium channel blocker in typical adult patients?

Calcium Channel Blocker Dosing: Starting and Maximum Doses

For typical adult patients, calcium channel blockers should be initiated at the lower end of the dosing range and titrated upward based on clinical response, with specific starting and maximum doses varying by agent and formulation. 1, 2

Dihydropyridine Calcium Channel Blockers

Amlodipine

• Starting dose: 5 mg once daily 1, 2
• Maximum dose: 10 mg once daily 1, 2
• Long duration of action with once-daily dosing 1

Nifedipine

• Immediate-release: 30 to 90 mg daily orally 1, 2
• Slow-release: 30 to 180 mg orally 1, 2
• Critical caveat: Immediate-release nifedipine must be avoided in the absence of concomitant beta blockade due to increased adverse potential 1, 2

Felodipine

• Starting dose: 5 mg once daily 1, 2
• Maximum dose: 10 mg once daily 1, 2

Nicardipine

• Dose: 20 to 40 mg three times daily 1, 2
• Short duration of action requiring multiple daily doses 1

Isradipine

• Dose: 2.5 to 10 mg twice daily 1, 2
• Medium duration of action 1

Nisoldipine

• Dose: 20 to 40 mg once daily 1, 2

Nitrendipine

• Dose: 20 mg once or twice daily 1, 2

Non-Dihydropyridine Calcium Channel Blockers

Diltiazem

• Immediate-release: 30 to 90 mg four times daily 1, 2
• Slow-release: 120 to 360 mg once daily 1, 2, 3
• Starting dose for SVT: 120 mg daily in divided or single dose with long-acting formulations 3
• Maximum dose: 360 mg daily 1, 2, 3

Verapamil

• Immediate-release: 80 to 160 mg three times daily 1, 2
• Slow-release: 120 to 480 mg once daily 1, 2, 3
• Starting dose for SVT: 120 mg daily in divided or single dose with long-acting formulations 3
• Maximum dose: 480 mg daily 1, 2, 3

Critical Safety Considerations

Contraindications and Precautions

• Verapamil and diltiazem should be avoided in patients with pulmonary edema or evidence of severe left ventricular dysfunction 1, 2
• Rapid-release, short-acting dihydropyridines (especially nifedipine) must be avoided without concomitant beta blockade due to increased risk of adverse cardiovascular events 1, 2
• Amlodipine and felodipine are reasonably well tolerated by patients with mild left ventricular dysfunction 1, 2

Common Side Effects by Class

• Dihydropyridines: Hypotension, dizziness, flushing, headache, peripheral edema 1, 2
• Non-dihydropyridines: Hypotension, bradycardia, myocardial depression, heart failure, edema 1, 2

Drug Interactions

• Diltiazem is a substrate of CYP3A4 (major) and a moderate CYP3A4 inhibitor, requiring caution with multiple medications including apixaban, cyclosporine, simvastatin 3
• Verapamil is a moderate CYP3A4 inhibitor and also inhibits P-glycoprotein; contraindicated with dofetilide 3
• Both agents require monitoring when combined with other AV nodal blocking drugs 3

Titration Strategy

• Always uptitrate from a lower dose to minimize adverse effects 4
• For extended-release preparations, tablets must be swallowed whole and cannot be crushed 5
• Monitor blood pressure, heart rate, and signs of heart failure during titration 1